Literature DB >> 25336857

If the Mountain Does Not Come to Mohammad: The Significance of Guest Operations for Early Stage Ovarian Cancer.

Inge T A Peters1, Carolien van Haaften1, J Baptist Trimbos1.   

Abstract

Background: In women with early ovarian cancer (EOC), comprehensive surgical staging is known to enhance ovarian cancer outcomes and requires specific surgical competence. Given that centralization of care remains a topic of continuing debate, a system of "guest operations" was introduced in the midwestern part of The Netherlands. During a guest operation a gynecologic oncologist participates in oncology surgery performed in the community hospital. Objective: This study was conducted to examine the effects of the presence of a gynecologic oncologist on the quality of staging, treatment, and survival in patients with EOC. Materials and
Methods: All patients with a pathologically confirmed diagnosis of EOC between January 2000 and December 2009 were selected from a regional cancer registry. Surgical accuracy was checked on the basis of each patient's file, operative notes, and pathology report.
Results: A total of 130 patients were included, of whom 15 were treated in the Leiden University Medical Center (LUMC) and 115 in eight regional community hospitals. If a gynecologic oncologist attended the operation, surgical staging was more often adequately performed, 81.1% versus 32.1% when a gynecologic oncologist was not present (p<0.001). Adherence to protocol was observed in 76.9% of operations when a gynecologic oncologist had been present, compared to 49.5% of patients who were treated by a general gynecologist alone (p=0.004). The 5-year disease-free survival was borderline significantly in favor of optimally staged patients, 75.1% in those who were not staged optimally versus 90.9% who were staged optimally (p=0.058). Conclusions: Guest operations deserve a distinguished place among the treatment modalities available to patients with EOC, because surgery by the most specialized and experienced surgeons contributes to better care. (J GYNECOL SURG 30:265).

Entities:  

Year:  2014        PMID: 25336857      PMCID: PMC4201240          DOI: 10.1089/gyn.2013.0088

Source DB:  PubMed          Journal:  J Gynecol Surg        ISSN: 1042-4067


  26 in total

1.  Ovarian cancer staging: does it require a gynecologic oncologist?

Authors:  A R Mayer; S K Chambers; E Graves; C Holm; P C Tseng; B E Nelson; P E Schwartz
Journal:  Gynecol Oncol       Date:  1992-11       Impact factor: 5.482

2.  Surgical treatment of ovarian cancer in different hospital categories--a prospective nation-wide study in Finland.

Authors:  Salla Kumpulainen; Tapio Kuoppala; Arto Leminen; Jorma Penttinen; Ulla Puistola; Eero Pukkala; Risto Sankila; Juha Mäkinen; Seija Grénman
Journal:  Eur J Cancer       Date:  2006-01-18       Impact factor: 9.162

3.  Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.

Authors:  Mirjam J A Engelen; Henrike E Kos; Pax H B Willemse; Jan G Aalders; Elisabeth G E de Vries; Michael Schaapveld; Renee Otter; Ate G J van der Zee
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

Review 4.  Epithelial ovarian carcinoma.

Authors:  G B Kristensen; C Tropé
Journal:  Lancet       Date:  1997-01-11       Impact factor: 79.321

Review 5.  Who should operate on patients with ovarian cancer? An evidence-based review.

Authors:  Kurt Christopher Giede; Katharina Kieser; Jason Dodge; Barry Rosen
Journal:  Gynecol Oncol       Date:  2005-08-29       Impact factor: 5.482

6.  Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.

Authors:  Deborah Schrag; Craig Earle; Feng Xu; Katherine S Panageas; K Robin Yabroff; Robert E Bristow; Edward L Trimble; Joan L Warren
Journal:  J Natl Cancer Inst       Date:  2006-02-01       Impact factor: 13.506

7.  Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.

Authors:  Craig C Earle; Deborah Schrag; Bridget A Neville; K Robin Yabroff; Marie Topor; Angela Fahey; Edward L Trimble; Diane C Bodurka; Robert E Bristow; Michael Carney; Joan L Warren
Journal:  J Natl Cancer Inst       Date:  2006-02-01       Impact factor: 13.506

Review 8.  Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature.

Authors:  Claes Tropé; Janne Kaern
Journal:  J Clin Oncol       Date:  2007-07-10       Impact factor: 44.544

9.  Predictors of comprehensive surgical treatment in patients with ovarian cancer.

Authors:  Barbara A Goff; Barbara J Matthews; Eric H Larson; C Holly A Andrilla; Michelle Wynn; Denise M Lishner; Laura-Mae Baldwin
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860

10.  International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.

Authors:  J Baptist Trimbos; Mahesh Parmar; Ignace Vergote; David Guthrie; Giorgio Bolis; Nicoletta Colombo; Jan B Vermorken; Valter Torri; Constantino Mangioni; Sergio Pecorelli; Andrea Lissoni; Ann Marie Swart
Journal:  J Natl Cancer Inst       Date:  2003-01-15       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.